Geode Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.3M Buy
5,955,739
+218,088
+4% +$690K ﹤0.01% 2110
2025
Q4
$21.2M Buy
5,737,651
+986,255
+21% +$3.19M ﹤0.01% 1971
2025
Q3
$12.6M Buy
4,751,396
+167,408
+4% +$324K ﹤0.01% 2277
2025
Q2
$4.51M Buy
4,583,988
+137,691
+3% +$138K ﹤0.01% 2781
2025
Q1
$6.4M Buy
4,446,297
+106,349
+2% +$196K ﹤0.01% 2536
2024
Q4
$9.55M Buy
4,339,948
+8,634
+0.2% +$20.1K ﹤0.01% 2408
2024
Q3
$7.15M Buy
4,331,314
+171,609
+4% +$347K ﹤0.01% 2569
2024
Q2
$9.24M Buy
4,159,705
+2,406,512
+137% +$5.66M ﹤0.01% 2370
2024
Q1
$4.7M Buy
1,753,193
+640,947
+58% +$1.56M ﹤0.01% 2737
2023
Q4
$3.33M Buy
1,112,246
+142,008
+15% +$184K ﹤0.01% 2898
2023
Q3
$951K Buy
970,238
+146,731
+18% +$212K ﹤0.01% 3347
2023
Q2
$1.14M Sell
823,507
-497,310
-38% -$694K ﹤0.01% 3297
2023
Q1
$2.1M Buy
1,320,817
+40,893
+3% +$211K ﹤0.01% 3001
2022
Q4
$7.97M Buy
1,279,924
+152,344
+14% +$1.09M ﹤0.01% 2406
2022
Q3
$7.55M Buy
1,127,580
+32,168
+3% +$221K ﹤0.01% 2438
2022
Q2
$6.97M Sell
1,095,412
-15,635
-1% -$88.7K ﹤0.01% 2502
2022
Q1
$5.16M Buy
1,111,047
+282,851
+34% +$1.21M ﹤0.01% 2783
2021
Q4
$4.14M Buy
828,196
+486,325
+142% +$3.89M ﹤0.01% 2999
2021
Q3
$4.12M Sell
341,871
-109,094
-24% -$1.59M ﹤0.01% 3022
2021
Q2
$9.54M Buy
450,965
+2,302
+0.5% +$55.4K ﹤0.01% 2490
2021
Q1
$12.6M Buy
448,663
+40,791
+10% +$1.2M ﹤0.01% 2201
2020
Q4
$10.6M Buy
407,872
+9,911
+2% +$297K ﹤0.01% 2136
2020
Q3
$14.8M Buy
397,961
+9,544
+2% +$378K ﹤0.01% 1731
2020
Q2
$19.9M Buy
388,417
+17,001
+5% +$711K ﹤0.01% 1514
2020
Q1
$11.7M Buy
371,416
+25,340
+7% +$1.34M ﹤0.01% 1638
2019
Q4
$20.6M Sell
346,076
-7,099
-2% -$319K ﹤0.01% 1540
2019
Q3
$12.9M Buy
353,175
+4,129
+1% +$164K ﹤0.01% 1754
2019
Q2
$16.2M Buy
349,046
+54,332
+18% +$2.55M ﹤0.01% 1626
2019
Q1
$11.8M Buy
294,714
+19,304
+7% +$866K ﹤0.01% 1781
2018
Q4
$12.7M Buy
275,410
+20,403
+8% +$983K ﹤0.01% 1621
2018
Q3
$11.3M Buy
255,007
+40,382
+19% +$1.85M ﹤0.01% 1825
2018
Q2
$8.41M Buy
214,625
+35,882
+20% +$1.81M ﹤0.01% 2007
2018
Q1
$12.9M Buy
178,743
+4,663
+3% +$342K ﹤0.01% 1580
2017
Q4
$11.5M Sell
174,080
-2,531
-1% -$136K ﹤0.01% 1638
2017
Q3
$8.85M Buy
176,611
+34,736
+24% +$1.67M ﹤0.01% 1819
2017
Q2
$6.57M Buy
141,875
+5,354
+4% +$197K ﹤0.01% 1960
2017
Q1
$4.82M Buy
136,521
+7,437
+6% +$170K ﹤0.01% 2141
2016
Q4
$1.62M Buy
129,084
+18,038
+16% +$215K ﹤0.01% 2751
2016
Q3
$1.54M Buy
111,046
+1,573
+1% +$17.8K ﹤0.01% 2708
2016
Q2
$1.08M Buy
109,473
+2,081
+2% +$34.5K ﹤0.01% 2861
2016
Q1
$1.81K Buy
107,392
+16,208
+18% +$261K ﹤0.01% 2532
2015
Q4
$2.03M Buy
91,184
+2,862
+3% +$72.2K ﹤0.01% 2476
2015
Q3
$2.08M Sell
88,322
-6,967
-7% -$437K ﹤0.01% 2417
2015
Q2
$7.79M Buy
95,289
+7,580
+9% +$742K ﹤0.01% 1594
2015
Q1
$8.12M Buy
87,709
+33,786
+63% +$2.18M ﹤0.01% 1541
2014
Q4
$2.18M Buy
53,923
+23,949
+80% +$733K ﹤0.01% 2373
2014
Q3
$733K Buy
29,974
+45
+0.2% +$715 ﹤0.01% 2972
2014
Q2
$474K Sell
29,929
-489
-2% -$7.07K ﹤0.01% 3188
2014
Q1
$459K Sell
30,418
-49
-0.2% -$761 ﹤0.01% 3187
2013
Q4
$418K Buy
30,467
+132
+0.4% +$1.92K ﹤0.01% 3157
2013
Q3
$572K Buy
+30,335
New +$510K ﹤0.01% 2879

Other funds holding ESPR